MENU
106th Global

Luis Paz-Ares

HOSP UNIV 12 OCTUBRE
Madrid / España
106th Global

Mentions data

Menciones por sus áreas de investigación
Clinical Medicine
  •   Twitter
  • 2.3K
  •   Wikipedia
  • 7
  •   News
  • 380
  •   Policy
  • 13

Mentions Chart

Influratio by dimension
  • Twitter
  • Wikipedia
  • News
  • Policy
PERSONA MENTIONS
  •   Twitter
  • 4.5K
  •   Wikipedia
  • 14
  •   News
  • 760
  •   Policy
  • 26

Trabajos con más influratio

Mentions   0   Wikipedia   140   News   2   Policy
Article Afatinib versus gefitinib as first-line treatment of patients with EGFR mutation-positive non-small-cell lung cancer (LUX-Lung 7): a phase 2B, open-label, randomised controlled trial Park, K; Tan, EH; O'Byrne, K; Zhang, L; Boyer, M; Mok, T; Hirsh, V; Yang, JCH; Lee, KH; Lu, S; Shi, Y; Kim, SW; Laskin, J; Kim, DW; Arvis, CD; Kolbeck, AK; Laurie, SA; Tsai, CM; Shahidi, M; Kim, M; Massey, D; Zazulina, V; Paz-Ares, L LANCET ONCOLOGY 1470-2045 (2016) DOI / 10.1016/s1470-2045(16)30033-x OPEN ACCESS LEVEL / NA
Mentions   1   Wikipedia   43   News   1   Policy
Article Nivolumab plus Ipilimumab in Lung Cancer with a High Tumor Mutational Burden Hellmann, MD; Ciuleanu, TE; Pluzanski, A; Lee, JS; Otterson, GA; Audigier-Valette, C; Minenza, E; Linardou, H; Burgers, S; Salman, P; Borghaei, H; Ramalingam, SS; Brahmer, J; Reck, M; O'Byrne, KJ; Geese, WJ; Green, G; Chang, H; Szustakowski, J; Bhagavathe NEW ENGLAND JOURNAL OF MEDICINE 0028-4793 (2018) DOI / 10.1056/nejmoa1801946 OPEN ACCESS LEVEL / Bronze, Green Accepted
Among researchers in Clinical Medicine
PROYECTO FINANCIADO POR PLAN NACIONAL DE INVESTIGACIÓN AGENCIA ESTATAL DE INVESTIGACIÓN, MINISTERIO DE CIENCIA E INNOVACIÓN. PID2019-109127RB-I00